-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Initiates Coverage On Braveheart Bio with Buy Rating, Announces Price Target of $48

Benzinga·08/31/2026 14:21:22
Listen to the news
Jefferies initiates coverage on Braveheart Bio (NASDAQ:BRVE) with a Buy rating and announces Price Target of $48.